[TNXP] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
15-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -41.96%
YoY- -52.23%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 3,779 0 0 2,914 -1 0 0 -
PBT -27,322 -31,680 -29,553 -17,021 -8,707 -7,588 -5,493 30.63%
Tax -0 5,611 -92,420 -7 -5 -11 -20 -
NP -27,322 -34,084 -29,553 -17,021 -11,181 -10,854 -5,493 30.63%
Tax Rate - - - - - - - -
Total Cost 31,101 34,084 29,553 19,935 11,181 10,854 5,493 33.48%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -723.00 0.00 0.00 -584.11 1,741,400.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -27.53 -111.06 -419.18 -664.75 0.00 0.00 0.00 -
EPS Diluted -27.53 -111.06 -419.18 -664.75 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.